Personnel Information

写真a

YOSHIMORI Mayumi


Job title

Project Assistant Professor

Campus Career 【 display / non-display

  • 2017.05
    -
    2017.09
    Tokyo Medical and Dental University, Graduate School of Health Care Sciences, Biomedical Laboratory Sciences, Moleculo-genetic Sciences, Laboratory Molecular Genetics of Hematology, Technical Assistant
  • 2017.10
    -
    2018.03
    Tokyo Medical and Dental University, Graduate School of Health Care Sciences, Biomedical Laboratory Sciences, Moleculo-genetic Sciences, Laboratory Molecular Genetics of Hematology, Project Assistant Professor
  • 2018.04
    -
    2019.03
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Biomedical Sciences and Engineering, Division of Biomedical Laboratory Sciences, Department of Laboratory Molecular Genetics of Hematology, Project Assistant Professor
  • 2019.04
    -
    2020.05
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Biomedical Sciences and Engineering, Division of Biomedical Laboratory Sciences, Department of Hematological Therapeutics, Project Assistant Professor
  • 2020.06
    -
    2021.02
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Biomedical Sciences and Engineering, Division of Biomedical Laboratory Sciences, Department of Hematological Therapeutics, Assistant Professor

display all >>

 

Published Papers & Misc 【 display / non-display

  • Arai Ayako, Takase Hiroshi, Yoshimori Mayumi, Yamamoto Kouhei, Mochizuki Manabu, Miura Osamu. Gene expression profiling of primary vitreoretinal lymphoma CANCER SCIENCE. 2020.04; 111 (4): 1417-1421. ( PubMed, DOI )

  • Masuda Azuchi, Isobe Yasushi, Sugimoto Koichi, Yoshimori Mayumi, Arai Ayako, Komatsu Norio. Efficient recruitment of c-FLIPL to the death-inducing signaling complex leads to Fas resistance in natural killer-cell lymphoma CANCER SCIENCE. 2020.03; 111 (3): 807-816. ( PubMed, DOI )

  • Yonese I, Takase H, Yoshimori M, Onozawa E, Tsuzura A, Miki T, Mochizuki M, Miura O, Arai A. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential. European journal of haematology. 2018.11; 102 (2): 191-196. ( PubMed, DOI )

  • 吉森 真由美, 新木 春香, 今留 謙一, 呉 詩星, 立石 萌, 小山 高敏, 新井 文子. EBV陽性NK腫瘍細胞は単球系・血管内皮細胞の凝固促進能を活性化しDICの原因となり得る(EBV-NK-cells induce procoagulant activity of monocytic and vascular endothelial cells causing DIC) 臨床血液. 2018.09; 59 (9): 1654. ( ichushi )

  • 新井 文子, 米瀬 一朗, 高瀬 博, 吉森 真由美, 三木 徹, 望月 學, 三浦 修. 原発性硝子体網膜リンパ腫におけるCD79B Y196変異(CD79B Y196 mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential) 臨床血液. 2018.09; 59 (9): 1494. ( ichushi )

display all >>

Conference Activities & Talks 【 display / non-display

  • Mayumi Yoshimori, Megumi Tateishi, Ayaka Ohashi, Shixing Wu, Ken-Ichi Imadome, Norio Shimizu, Miwako Nishio, Ayako Arai. Products of EBV-Positive Neoplastic NK-Cells Induce Differentiation into Macrophages and Procoagulant Activity of Monocytes, which Leads to HLH. Virtual 25th EHA Congress 2020.06.12

  • Onozawa Erika, Shibayama Haruna, Takada Honami, Imadome Ken-ichi, Aoki Sho, Yoshimori Mayumi, Fujiwara Shigeyoshi, Koyama Takatoshi, Miura Osamu, Arai Ayako. 慢性活動性Epstein-Barrウイルス感染症ではSTAT3が恒常的に活性化し治療標的となりうる(STAT3 is constitutively activated in CAEBV and can be a therapeutic target). 臨床血液 2017.09.01

  • Tsuzura Akiho, Imadome Ken-ichi, Ouchi Fumihiko, Shibayama Haruna, Ohara Osamu, Imai Kohsuke, Matsuda Go, Onozawa Erika, Yoshimori Mayumi, Koyama Takatoshi, Miura Osamu, Arai Ayako. 慢性活動性EBウイルス感染症におけるAPOBEC3Bの発現亢進(Upregulation of APOBEC3B expression in chronic active Epstein-Barr virus infection). 臨床血液 2017.09.01